UroGen Pharma Ltd. Share Price
NASDAQ: URGN | Small CapUroGen Pharma Ltd. Stock Performance
UroGen Pharma Ltd. Share Price Today
As of 31 October 2026, UroGen Pharma Ltd.'s share price is $32.72. The stock opened at $33.42, compared to its previous close of $33.53. During today's trading session, UroGen Pharma Ltd.'s share price traded between $32.39 and $33.49, with an average price of $32.94. Over the past 52 weeks, the stock has recorded a high of $50.76 and a low of $16.61. In terms of performance, UroGen Pharma Ltd.'s share price has risen by 37.25% over the last six months and is up 60.00% on a year-on-year basis.
UroGen Pharma Ltd. Share Price Chart
UroGen Pharma Ltd. Quarterly Profit & Loss
All figures in USD
UroGen Pharma Ltd. Annual Profit & Loss
All figures in USD
About UroGen Pharma Ltd.
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.
UroGen Pharma Ltd. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $40.89 | $32.69 | -19.72% |
Sep 2026 | $42.98 | $40.72 | -10.59% |
Aug 2026 | $37.41 | $45.55 | +19.29% |
Jul 2026 | $37.39 | $38.18 | +3.75% |
Jun 2026 | $27.70 | $36.80 | +30.87% |
May 2026 | $23.93 | $28.12 | +17.95% |
Apr 2026 | $18.27 | $23.84 | +32.59% |
Mar 2026 | $21.39 | $17.98 | -17.20% |
Feb 2026 | $19.42 | $21.71 | +10.71% |
Jan 2026 | $23.73 | $19.61 | -16.48% |
Dec 2025 | $28.45 | $23.48 | -18.34% |
Nov 2025 | $20.29 | $28.76 | +40.64% |